France’s Ministry of Health announced today that the nation has officially approved the legalization of Sativex, a medicinal spray made from the cannabis plant.
The approval of Sativex is the first cannabis-based medical product approved by France; in June, lawmakers approved legislation which allows the nation to accept cannabis medicines, with the National Security Agency of Medicines and Health Products reviewing applications. Specifically, the proposal enables “the issuance of an authorization for placing on the market of medicinal products containing cannabis or its derivatives”.
France now becomes the 24th country to approve Sativex, which is made up of one part THC (tetrahydrocannabinol), and one part CBD (cannabidiol). Switzerland was the most recent nation to approve its use in November.